BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Potential of Lux Biosciences’ LUVENIQ (LX211) as First Disease Modifying Treatment for Sight-Threatening Non-Infectious Uveitis Highlighted at American Academy of Ophthalmology

  October 26, 2009

   · 

  1 min read
• Genetown

  Idera Pharmaceuticals, Inc. Announces Issuance of Patents Covering its Novel Toll-like Receptor-Targeted Compounds and Their Use

  October 26, 2009

   · 

  1 min read
• Business

  Completion of CEL-SCI’s New Facility Signals That Long Awaited Phase III Trial is Imminent

  October 26, 2009

   · 

  1 min read
• Business

  Bruker Corporation Plans to Release Third Quarter 2009 Financial Results on October 29, 2009

  October 26, 2009

   · 

  1 min read
• Compugen Ltd. Presents DAC Blockers Platform and Initial Product Candidates at Fifth Peptide Engineering Meeting in Barcelona, Spain

  October 26, 2009

   · 

  1 min read
• Biotech Beach

  Spectrum Pharmaceuticals, Inc. to Present at the 2009 BIOCOM Investor Conference

  October 26, 2009

   · 

  1 min read
• Business

  Salix Pharmaceuticals, Ltd. Announces 3Q2009 Financial Results Conference Call and Webcast

  October 26, 2009

   · 

  1 min read
• Business

  Ceragenix Pharmaceuticals, Inc. Release: Second Partner Exercises Option for Exclusive Period to Negotiate Licensing Terms for CeraShield™ Antimicrobial Coating Application

  October 26, 2009

   · 

  1 min read
• Pharm Country

  Pulmo BioTech Announces Cash Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the European Market

  October 26, 2009

   · 

  5 min read
• Drug Development

  Positive Data from Two Investigator-Initiated Studies with Santarus Inc.’ ZEGERID to Be Presented At American College of Gastroenterology

  October 26, 2009

   · 

  1 min read